Cargando…
Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer
PURPOSE: In radical radiotherapy for cervical cancer, high-dose-rate (HDR) brachytherapy is commonly used after external beam radiation therapy (EBRT) to deliver a cumulative EQD(2) of 80 to 90 Gy to the primary tumor. However, there is less certainty regarding brachytherapy dose contribution to the...
Autores principales: | Chua, Gail Wan Ying, Foo, Yong Wee, Tay, Guan Heng, Tan, David Boon Harn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611454/ https://www.ncbi.nlm.nih.gov/pubmed/28951754 http://dx.doi.org/10.5114/jcb.2017.69237 |
Ejemplares similares
-
The rectum and bladder doses in intracavitary brachytherapy for cervical cancer
por: Sharma, Brahmacharimayum Arunkumar, et al.
Publicado: (2011) -
Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer
por: Sharma, B. Arunkumar, et al.
Publicado: (2011) -
Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
por: Itami, Jun, et al.
Publicado: (2022) -
Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators
por: Moghani, Mona Malekzadeh, et al.
Publicado: (2022) -
Estimating the accumulative dose uncertainty for intracavitary and interstitial brachytherapy
por: Wang, Binbing, et al.
Publicado: (2021)